Tenet Healthcare (THC) Projects 17.73% EPS Growth in Upcoming Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 27 2025
0mins
Source: NASDAQ.COM
- Stock Performance: Tenet Healthcare's shares closed at $200.60, rising 1.43% from the previous session, outperforming the S&P 500's slight decline of 0.03%, indicating market confidence in its short-term performance.
- Earnings Expectations: The upcoming earnings report is projected to show earnings per share (EPS) of $4.05, reflecting a 17.73% increase from the same quarter last year, suggesting an improvement in profitability that may attract more investor interest.
- Revenue Forecast: The Zacks Consensus Estimate anticipates net sales of $5.45 billion for Tenet Healthcare, representing a 7.44% year-over-year growth, highlighting the company's robust growth trajectory within the healthcare sector.
- Valuation Analysis: Tenet Healthcare currently trades at a forward P/E ratio of 12.25, significantly above the industry average of 8.73, indicating high market expectations for future growth, while its PEG ratio of 0.86 suggests a relatively reasonable growth outlook.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy THC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on THC
Wall Street analysts forecast THC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THC is 241.36 USD with a low forecast of 224.00 USD and a high forecast of 260.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
15 Buy
0 Hold
0 Sell
Strong Buy
Current: 189.490
Low
224.00
Averages
241.36
High
260.00
Current: 189.490
Low
224.00
Averages
241.36
High
260.00
About THC
Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The Company's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. It also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The Company operates a Global Business Center in the Philippines.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BofA Cautious on Hospitals, Forecasts 2-4% EBITDA Headwind Over Next 5 Years
- Dismal Industry Outlook: BofA Securities forecasts a 2-4% annual EBITDA headwind for hospitals over the next five years due to cuts from the Reconciliation Bill and the expiration of enhanced exchange subsidies, negatively impacting revenue and margins.
- Increased Policy Risks: Analysts note that while some new state-directed payment programs may be approved, future policy changes could further suppress hospital profitability, particularly concerning Medicaid and exchange policies.
- Intensified Market Competition: With healthcare demand stabilizing, core demand for hospital services is expected to grow below the midpoint of long-term ranges in 2026, as policy changes may lead to lower-than-expected volume growth for hospitals.
- Shift in Investment Preferences: BofA favors post-acute care companies like Encompass Health due to their minimal exposure to upcoming cuts, anticipating higher visibility growth, which reflects a positive outlook on favorable industry dynamics.
Continue Reading
Tenet Healthcare (THC) Projects 17.73% EPS Growth in Upcoming Earnings
- Stock Performance: Tenet Healthcare's shares closed at $200.60, rising 1.43% from the previous session, outperforming the S&P 500's slight decline of 0.03%, indicating market confidence in its short-term performance.
- Earnings Expectations: The upcoming earnings report is projected to show earnings per share (EPS) of $4.05, reflecting a 17.73% increase from the same quarter last year, suggesting an improvement in profitability that may attract more investor interest.
- Revenue Forecast: The Zacks Consensus Estimate anticipates net sales of $5.45 billion for Tenet Healthcare, representing a 7.44% year-over-year growth, highlighting the company's robust growth trajectory within the healthcare sector.
- Valuation Analysis: Tenet Healthcare currently trades at a forward P/E ratio of 12.25, significantly above the industry average of 8.73, indicating high market expectations for future growth, while its PEG ratio of 0.86 suggests a relatively reasonable growth outlook.
Continue Reading